Richardson Centre for Functional Foods and Nutraceuticals
Winnipeg, Manitoba, R3T 2N2, Canada
NCT Number: NCT02402517
The objectives are to test the acute effects of different extruded pulse snacks on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite on an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of food products containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of extruded pulse snacks will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Winnipeg, Manitoba, R3T 2N2, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non pulse extruded snack
Pulse extruded snack
Pulse extruded snack
Pulse extruded snack
Pulse extruded snack
Pulse extruded snack
Time frame: 0 - 240 min
Measured in blood using intravenous catheter at 14 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)
Time frame: at 120 min
Ad-libitum meal. Food consumed measured by weight.
Time frame: 0-240 min
Measured by VAS questionnaire at 14 time points, used to calculate area under curve (AUC).( Composite measure)
Time frame: 60 minutes
Sixty minute exercise protocol at minutes 60 to 120. Oxygen consumption measured during exercise at 3 time points.
Time frame: 60 minutes
60 minute exercise protocol at minutes 60 to 120. Measured before, during, and exercise exercise at 3 time points
Time frame: at 5 minutes
Measured by VAS questionnaire
Time frame: at 260 minutes
Measured by VAS questionnaire
Time frame: 0-240 min
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
Time frame: 0-240 min
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
Time frame: 60-120 min
Heart rate monitored over a 60 minute exercise protocol. To monitor exercise intensity and give a measure of fatigue (cardiovascular drift)
Time frame: 60 minutes
Measured during 60 minute exercise protocol at minutes 60-120. Respiratory quotient measured during exercise at 3 time points.
University of Manitoba
Other
Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT01501201
Body Weight, Diabetes
Lille, Nord, France
View Trial Details